Orlistat influence on clinical, hormonal and metabolic parameters of obese patients with high risk of type 2 diabetes and cardiovascular diseases

被引：0
|
作者：
Boutrova, S [1 ]
Ershova, E [1 ]
Ilyin, A [1 ]
Kolesnikova, G [1 ]
机构：
[1] Russian Endocrinol Res Ctr, Moscow, Russia
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2004年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [41] Cardiovascular risk in patients with diabetes type 2 with or without associated metabolic syndrome
    Munoz Roldan, Inmaculada
    Martin Puig, Maria Belen
    Agudo Villa, Maria Teresa
    Garcia Andrade, Carlos Recarte
    Millan Nunez-Cortes, Jesus
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (03): : 112 - 118
  • [42] The Impact of Dietary and Metabolic Risk Factors on Cardiovascular Diseases and Type 2 Diabetes Mortality in Brazil
    Otto, Marcia C. de Oliveira
    Afshin, Ashkan
    Micha, Renata
    Khatibzadeh, Shahab
    Fahimi, Saman
    Singh, Gitanjali
    Danaei, Goodarz
    Sichieri, Rosely
    Monteiro, Carlos A.
    Louzada, Maria L. C.
    Ezzati, Majid
    Mozaffarian, Dariush
    PLOS ONE, 2016, 11 (03):
  • [43] Urinary Proteomics in Patients with Type 2 Diabetes at High Cardiovascular Risk
    Currie, Gemma E.
    Friar, Matthew
    Brown, Catriona E.
    Flynn, Joanne
    Mullen, William
    Mischak, Harald
    Delles, Christian
    HYPERTENSION, 2014, 64
  • [44] Improvement of metabolic control in obese type 2 diabetic patients treated with orlistat for 6 months
    Guy-Grand, B
    Valensi, P
    Drouin, P
    Gin, H
    Eschwege, E
    DIABETES, 2001, 50 : A436 - A436
  • [45] Cardiovascular risk in patients with type 2 diabetes
    Parmar, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (09) : 1160 - 1160
  • [46] Role of Metabolic Surgery in Less Obese or Non-Obese Subjects with Type 2 Diabetes: Influence Over Cardiovascular Events
    Ricardo Cohen
    Pedro Paulo Caravatto
    Tarissa Petry
    David Cummings
    Current Atherosclerosis Reports, 2013, 15
  • [47] Role of Metabolic Surgery in Less Obese or Non-Obese Subjects with Type 2 Diabetes: Influence Over Cardiovascular Events
    Cohen, Ricardo
    Caravatto, Pedro Paulo
    Petry, Tarissa
    Cummings, David
    CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (10)
  • [48] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [49] Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk
    Stalenhoef, A. F. H.
    Davidson, M. H.
    Robinson, J. G.
    Burgess, T.
    Duttlinger-Maddux, R.
    Kallend, D.
    Goldberg, A. C.
    Bays, H.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 30 - 39
  • [50] The role of metabolic surgery in obese patients with type 2 diabetes
    Shervashidze, T.
    Kvanchakhadze, R.
    Abuladze, D.
    Jashi, L.
    Shervashidze, M.
    Chakvetadze, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
12345